The Universal Molecular Processing System, uMPS, is comprised of task-specific modules that can allow for the quantification of low-abundance markers directly from blood and score the presence of sequence variations from either DNA or RNA that have diagnostic significance for managing a variety of diseases. Unique to the uMPS is that it will be able to search for any blood-borne marker and analyze a variety of different genetic variations.
The uMPS is comprised of task-specific modules with each module optimized independently and manufactured in plastics via replication. Unique to the uMPS is that both microfluidic and nanofluidic modules will be incorporated into it to provide some unique processing capabilities, such as high multiplexing capacity, short processing time and exquisite clinical sensitivity and specificity.
In its final form, the uMPS will accept whole blood directly and search for rare cells such as CTCs, cell free DNA and/or exosomes. Once these markers have been selected from whole blood, they can be genetically profiled using unique molecular assays that the Center is producing.